Accumulation of prelamin A compromises NF-κB-regulated B-lymphopoiesis in a progeria mouse model

Longevity & Healthspan

Zhongjun Zhou¹  Fengju Zhang³  Keyuan Zhou²  Xinguang Liu²  Shuangcheng Zhou¹  Baohua Liu² 

[1] Department of Biochemistry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong;Guangdong Medical College, 1 Xin Cheng Avenue, Dongguan, 523808, China;Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China

关键词: NF-κB;    B-lymphopoiesis;    Lamin A;    Zmpste24;    Hutchinson-Gilford progeria syndrome (HGPS);    Aging;   

Others  :  804009
DOI  :  10.1186/2046-2395-2-1

 received in 2012-06-08, accepted in 2012-11-06,  发布年份 2013

【 摘 要 】

Background

Alteration in the immune system is one of the most profound aspects of aging. Progressive changes in the number of B lymphocyte progenitors during aging have been reported but the underlying mechanisms are still elusive. A heterozygous G608G mutation in the LMNA gene leads to a deletion of 50 amino acids in lamin A protein, termed progerin, and is the predominant cause of Hutchinson-Gilford progeria syndrome (HGPS). Lack of Zmpste24, a metalloproteinase responsible for prelamin A processing, leads to progeroid features resembling HGPS. Therefore Zmpste24-deficient mice provide an ideal mouse model to study the impact of lamin A and (premature) aging on the aging-related decline of B lymphopoiesis.

Results

Analysis of bone marrow (BM) nucleated cells revealed a decline of early B cell progenitors in Zmpste24^−/− mice. BM transplantation in a congenic strain completely rescued the defects in B lymphopoiesis, indicating that the decline in B cell progenitors in Zmpste24^−/− mice is attributable to defective BM microenvironments rather than to cell-intrinsic defects. Further investigation revealed downregulation of a set of important early B lymphopoiesis factors in Zmpste24^−/− bone marrow stromal cells (BMSCs), such as Vcam-1, SDF-1α, Flt3L and TSLP, and most of them are under transcriptional control of NF-κB signaling. Though TNFα stimulates IκBα degradation and NF-κB nuclear translocation in Zmpste24^−/− BMSCs, NF-κB fails to stimulate IκBα re-expression, which mediates a negative feedback loop of NF-κB signaling in wild-type BMSCs.

Conclusions

Our data demonstrate a cell-extrinsic defect of B cell development in a progeroid mouse model and a critical role for lamin A in the regulation of NF-κB signaling and cytokines that are essential for lymphopoiesis.

【 授权许可】

   
2013 Liu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Gilbert SF: Developmental Biology. 6th edition. Sunderland: SINAUER ASSOCIATES, INC; 2000.
• [2]Ghia P, Melchers F, Rolink AG: Age-dependent changes in B lymphocyte development in man and mouse. Exp Gerontol 2000, 35:159-165.
• [3]Goronzy JJ, Weyand CM: T cell development and receptor diversity during aging. Curr Opin Immunol 2005, 17:468-475.
• [4]Solana R, Pawelec G, Tarazona R: Aging and innate immunity. Immunity 2006, 24:491-494.
• [5]Weng NP: Aging of the immune system: how much can the adaptive immune system adapt? Immunity 2006, 24:495-499.
• [6]Pistoresi-Palencia MC, Romero-Piffiguer M, Moron G, Ferro ME: Effect of aging on autoimmune response to rat male accessory glands: young, but not aged, antigen-presenting cells efficiently induce suppression in aged rats. Mech Ageing Dev 1994, 76:33-41.
• [7]Bassing CH, Alt FW: The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst) 2004, 3:781-796.
• [8]Ogawa M, ten Boekel E, Melchers F: Identification of CD19(−)B220(+)c-Kit(+)Flt3/Flk-2(+)cells as early B lymphoid precursors before pre-B-I cells in juvenile mouse bone marrow. Int Immunol 2000, 12:313-324.
• [9]Li YS, Wasserman R, Hayakawa K, Hardy RR: Identification of the earliest B lineage stage in mouse bone marrow. Immunity 1996, 5:527-535.
• [10]Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K: Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991, 173:1213-1225.
• [11]Allman D, Li J, Hardy RR: Commitment to the B lymphoid lineage occurs before DH-JH recombination. J Exp Med 1999, 189:735-740.
• [12]Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, Weissman IL: Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005, 102:9194-9199.
• [13]Hennekam RC: Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 2006, 140:2603-2624.
• [14]Pollex RL, Hegele RA: Hutchinson-Gilford progeria syndrome. Clin Genet 2004, 66:375-381.
• [15]Beck LA, Hosick TJ, Sinensky M: Isoprenylation is required for the processing of the lamin A precursor. J Cell Biol 1990, 110:1489-1499.
• [16]Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, Hultenby K, Astudillo A, Wernerson A, Rodriguez F, Tryggvason K, Lopez-Otin C: Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 2002, 31:94-99.
• [17]Bergo MO, Gavino B, Ross J, Schmidt WK, Hong C, Kendall LV, Mohr A, Meta M, Genant H, Jiang Y, Wisner ER, Van Bruggen N, Carano RA, Michaelis S, Griffey SM, Young SG: Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci USA 2002, 99:13049-13054.
• [18]Rusinol AE, Sinensky MS: Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors. J Cell Sci 2006, 119:3265-3272.
• [19]Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS: Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003, 423:293-298.
• [20]Reddel CJ, Weiss AS: Lamin A expression levels are unperturbed at the normal and mutant alleles but display partial splice site selection in Hutchinson-Gilford progeria syndrome. J Med Genet 2004, 41:715-717.
• [21]Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B: Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999, 147:913-920.
• [22]Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM, Zhou Z, Rodriguez FJ, Stewart CL, Vega JA, Tryggvason K, Freije JM, López-Otín C: Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 2005, 437:564-568.
• [23]Fong LG, Ng JK, Meta M, Cote N, Yang SH, Stewart CL, Sullivan T, Burghardt A, Majumdar S, Reue K, Bergo MO, Young SG: Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc Natl Acad Sci USA 2004, 101:18111-18116.
• [24]Scaffidi P, Misteli T: Lamin A-dependent nuclear defects in human aging. Science 2006, 312:1059-1063.
• [25]Candelario J, Sudhakar S, Navarro S, Reddy S, Comai L: Perturbation of wild-type lamin A metabolism results in a progeroid phenotype. Aging Cell 2008, 7:355-367.
• [26]Kudlow BA, Stanfel MN, Burtner CR, Johnston ED, Kennedy BK: Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53. Mol Biol Cell 2008, 19:5238-5248.
• [27]McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K: The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One 2007, 2:e1269.
• [28]Cao K, Blair CD, Faddah DA, Kieckhaefer JE, Olive M, Erdos MR, Nabel EG, Collins FS: Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. J Clin Invest 2011, 121:2833-2844.
• [29]Hale JS, Frock RL, Mamman SA, Fink PJ, Kennedy BK: Cell-extrinsic defective lymphocyte development in Lmna(−/−) mice. PLoS One 2010, 5:e10127.
• [30]Riley RL, Kruger MG, Elia J: B cell precursors are decreased in senescent BALB/c mice, but retain normal mitotic activity in vivo and in vitro. Clin Immunol Immunopathol 1991, 59:301-313.
• [31]Stephan RP, Sanders VM, Witte PL: Stage-specific alterations in murine B lymphopoiesis with age. Int Immunol 1996, 8:509-518.
• [32]Johnson KM, Owen K, Witte PL: Aging and developmental transitions in the B cell lineage. Int Immunol 2002, 14:1313-1323.
• [33]Wilson A, Trumpp A: Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006, 6:93-106.
• [34]Schaumann DH, Tuischer J, Ebell W, Manz RA, Lauster R: VCAM-1-positive stromal cells from human bone marrow producing cytokines for B lineage progenitors and for plasma cells: SDF-1, flt3L, and BAFF. Mol Immunol 2007, 44:1606-1612.
• [35]Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T: Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004, 20:707-718.
• [36]Iademarco MF, McQuillan JJ, Rosen GD, Dean DC: Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992, 267:16323-16329.
• [37]Lee HC, Ziegler SF: Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc Natl Acad Sci USA 2007, 104:914-919.
• [38]Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR: The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 2002, 17:525-535.
• [39]Vallabhapurapu S, Karin M: Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009, 27:693-733.
• [40]Hoffmann A, Levchenko A, Scott ML, Baltimore D: The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 298:1241-1245.
• [41]Whitlock CA, Witte ON: Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 1982, 79:3608-3612.
• [42]Ryan DH, Nuccie BL, Abboud CN, Winslow JM: Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J Clin Invest 1991, 88:995-1004.
• [43]Dittel BN, McCarthy JB, Wayner EA, LeBien TW: Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 1993, 81:2272-2282.
• [44]Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA: Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med 2001, 193:741-754.
• [45]Leuker CE, Labow M, Muller W, Wagner N: Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response. J Exp Med 2001, 193:755-768.
• [46]Egawa T, Kawabata K, Kawamoto H, Amada K, Okamoto R, Fujii N, Kishimoto T, Katsura Y, Nagasawa T: The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor. Immunity 2001, 15:323-334.
• [47]Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998, 95:9448-9453.
• [48]Kawabata K, Ujikawa M, Egawa T, Kawamoto H, Tachibana K, Iizasa H, Katsura Y, Kishimoto T, Nagasawa T: A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci USA 1999, 96:5663-5667.
• [49]Ma Q, Jones D, Springer TA: The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999, 10:463-471.
• [50]Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, Mosley B, March CJ, Urdal D, Gillis S: Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988, 333:571-573.
• [51]von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995, 181:1519-1526.
• [52]Namikawa R, Muench MO, de Vries JE, Roncarolo MG: The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 1996, 87:1881-1890.
• [53]Ray RJ, Furlonger C, Williams DE, Paige CJ: Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol 1996, 26:10-16.
• [54]Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT: Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 2004, 113:370-378.
• [55]Columbaro M, Capanni C, Mattioli E, Novelli G, Parnaik VK, Squarzoni S, Maraldi NM, Lattanzi G: Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. Cell Mol Life Sci 2005, 62:2669-2678.
• [56]Shumaker DK, Dechat T, Kohlmaier A, Adam SA, Bozovsky MR, Erdos MR, Eriksson M, Goldman AE, Khuon S, Collins FS, Jenuwein T, Goldman RD: Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc Natl Acad Sci USA 2006, 103:8703-8708.
• [57]Meirelles Lda S, Nardi NB: Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 2003, 123:702-711.
• [58]Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, Cao Y, Cheah KS, Tryggvason K, Zhou Z: Genomic instability in laminopathy-based premature aging. Nat Med 2005, 11:780-785.
• [59]Schneider CA, Rasband WS, Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nature methods 2012, 9:671-675.